ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Second-Generation Tyrosine Kinase Inhibitors (Pazopanib) in Renal Cell Carcinoma: Current Status
Renal Cell Carcinoma
◽
10.1007/978-1-4939-1622-1_9
◽
2014
◽
pp. 207-216
Author(s):
Linda Cerbone
◽
Cora N. Sternberg
Keyword(s):
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Tyrosine Kinase Inhibitors
◽
Renal Cell
◽
Second Generation
◽
Kinase Inhibitors
◽
Current Status
Download Full-text
Related Documents
Cited By
References
Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
Therapeutic Advances in Urology
◽
10.1177/17562872211029784
◽
2021
◽
Vol 13
◽
pp. 175628722110297
Author(s):
Giandomenico Roviello
◽
Sebastiano Buti
◽
Carlo Cattrini
◽
Alessia Mennitto
◽
Carlo Messina
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Tyrosine Kinase Inhibitors
◽
Renal Cell
◽
Kinase Inhibitors
◽
Line Treatment
◽
First Line
◽
Increased Risk
◽
First Line Treatment
Download Full-text
Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors
OncoTargets and Therapy
◽
10.2147/ott.s45872
◽
2013
◽
pp. 679
◽
Cited By ~ 1
Author(s):
Daniel Cho
Keyword(s):
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Tyrosine Kinase Inhibitors
◽
Renal Cell
◽
Kinase Inhibitors
◽
Prognostic Biomarkers
◽
Advanced Renal Cell Carcinoma
Download Full-text
Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis
European Urology
◽
10.1016/j.eururo.2008.10.021
◽
2009
◽
Vol 55
(6)
◽
pp. 1430-1439
◽
Cited By ~ 69
Author(s):
Manfred Johannsen
◽
Anne Flörcken
◽
Axel Bex
◽
Jan Roigas
◽
Marco Cosentino
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Retrospective Analysis
◽
Tyrosine Kinase Inhibitors
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Kinase Inhibitors
◽
Complete Response
◽
Response To Treatment
Download Full-text
Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis
Clinical Genitourinary Cancer
◽
10.1016/j.clgc.2014.10.002
◽
2015
◽
Vol 13
(4)
◽
pp. 280-286
◽
Cited By ~ 13
Author(s):
Andreas Nearchou
◽
Antonis Valachis
◽
Pehr Lind
◽
Olof Akre
◽
Per Sandström
Keyword(s):
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Tyrosine Kinase Inhibitors
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Kinase Inhibitors
◽
Meta Analysis
◽
Predictive Marker
Download Full-text
Additional Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Renal Cell Carcinoma
◽
10.1007/978-1-59745-332-5_10
◽
2009
◽
pp. 189-193
Author(s):
Brian I. Rini
Keyword(s):
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Tyrosine Kinase Inhibitors
◽
Renal Cell
◽
Kinase Inhibitors
Download Full-text
PD57-08 TUMORAL CD8+ T CELLS CORRELATE WITH FAVORABLE OUTCOME IN METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS
The Journal of Urology
◽
10.1016/j.juro.2018.02.2652
◽
2018
◽
Vol 199
(4S)
◽
Author(s):
Jiajun Wang
◽
Li Liu
◽
Wei Xi
◽
Jiejie Xu
◽
Jianming Guo
Keyword(s):
Renal Cell Carcinoma
◽
T Cells
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Tyrosine Kinase Inhibitors
◽
Metastatic Renal Cell Carcinoma
◽
Cd8 T Cells
◽
Renal Cell
◽
Kinase Inhibitors
◽
Favorable Outcome
Download Full-text
Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma
OncoImmunology
◽
10.1080/2162402x.2018.1515611
◽
2018
◽
Vol 8
(1)
◽
pp. e1515611
Author(s):
Jiajun Wang
◽
Li Liu
◽
Qi Bai
◽
Chenzhang Ou
◽
Ying Xiong
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Tyrosine Kinase Inhibitors
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Kinase Inhibitors
◽
Therapeutic Benefit
Download Full-text
Treatable causes of diarrhoea in patients on tyrosine kinase inhibitors for metastatic renal cell carcinoma
Annals of Oncology
◽
10.1093/annonc/mdy469
◽
2019
◽
Vol 30
(1)
◽
pp. 150-151
Author(s):
S.V. Lightowlers
◽
B. Greef
◽
T. Eisen
◽
A. Matakidou
◽
K. Fife
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Tyrosine Kinase Inhibitors
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Kinase Inhibitors
Download Full-text
Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma - What Should We Tell Our Patients?
International Journal of Surgery
◽
10.1016/j.ijsu.2017.08.062
◽
2017
◽
Vol 47
◽
pp. S8
Author(s):
J. Cobley
◽
G. Broadley
◽
F. Khan
◽
K. Harvey
◽
C. Parry
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Tyrosine Kinase Inhibitors
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Kinase Inhibitors
Download Full-text
Adjuvant tyrosine kinase inhibitors for renal cell carcinoma? No, thank you (at least for the present)
Future Oncology
◽
10.2217/fon-2018-0304
◽
2018
◽
Vol 14
(22)
◽
pp. 2223-2224
◽
Cited By ~ 2
Author(s):
Alessandro Leonetti
◽
Teresa Zielli
◽
Sebastiano Buti
Keyword(s):
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Cell Carcinoma
◽
Tyrosine Kinase Inhibitors
◽
Renal Cell
◽
Kinase Inhibitors
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close